研究成果
年分
作者
期刊
研究名稱
2024
Allamsetty S, Lin CY*, Lin YJ, Chen SA.
PACE-Pacing Clin. Electrophysiol. 2024; 47(12):1611-1613. (IF:1.700)
Spontaneous Conversion of a Long RP to Short RP Tachycardia: What Is the Mechanism?
2024
Amadis MR, Lo LW, Salim S, Yamin M, Lin YJ, Chang SL, Hu YF, Chung FP, Sukardi R, Lin CY, Chang TY, Kuo L, Pramudita A, Liu CM, Liu SH, Wu C, Huang YS, Nguyen DSN,Tran DC, Chen SA.
PACE-Pacing Clin. Electrophysiol. 2024;doi: 10.1111/pace.15118. (IF:1.700)
Multistep Algorithm to Predict RVOT PVC Site of Origin for Successful Ablation Using Available Criteria: A Two-Center Cross-Validation Study.
2024
Bucci T, Nabrdalik K, Shantsila A, Romiti GF, Teo WS, Park HW, Shimizu W, Tse HF, Proietti M, Chao TF, Lip GYH*
J. Clin. Med. 2024; 13(5):1274. (IF:3.000)
Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
2024
Bucci T, Romiti GF, Shantsila A, Teo WS, Park HW, Shimizu W, Corica B, Proietti M, Tse HF, Chao TF*, Frost F, Lip GYH*.
J. Am. Heart Assoc. 2024; 13(7):e032785. (IF:5.000)
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
2024
Bucci T, Romiti GF, Corica B, Shantsila A, Teo WS, Park HW, Shimizu W, Tse HF, Proietti M, Chao TF, Lip GYH*.
Minerva Med. 2024; 115(3):308-319. (IF:1.820)
Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.
2024
Chan YH, Chao TF, Chen SW, Lee HF, Li PR, Yeh YH, Kuo CT, See LC*, Lip GYH.
J. Clin. Endocrinol. Metab. 2024; 109(10):2617-2629. (IF: 5.000)
SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation.
2024
Chang HC, Chen YY, Kuo TT, Lin YJ, Chien KL, Chang HY, Hung CL*, Chung FP*.
J. Am. Heart Assoc. 2024; 13(8): e032397. (IF:5.000)
Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study.
2024
Chan YH, Chen SW, Chan CY, Chao TF*.
J. Formos. Med. Assoc. 2024; 123(5): 578-586. (IF:2.600)
Comparative safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation: A network meta-analysis.
2024
Chan YH, See LC, Chao TF*.
EUR. HEART J.-CARDIOVASC. PHARMACOTHER. 2024; 10(4):365. (IF:5.400)
Reply to Letter to the Editor by Thompson et al.
2024
Chang CC*, Sung WT, Lu YW, Chuang MJ, Lee YH, Tsai YL, Chou RH, Huang SS, Huang PH*.
Clin. Cardiol. 2024; 47(7): e24317. (IF:2.400)
Real-World Clinical Performance of a Novolimus-Eluting Stent Versus a Sirolimus-Eluting Stent.